Central Auditory Processing Disorder denials in California external review

In the California DMHC record, independent physician reviewers decided 18 published external-review cases involving central auditory processing disorderand overturned the plan’s denial in 44.4%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
18
2004–2025
Overturned
44.4%
8 denials reversed

Most-fought treatments for central auditory processing disorder

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Speech Therapy3
66.7%
Typical time to a decision
21 days
Most land between 14 and 24 days

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: The parents of the patient requested authorization and coverage for audiology services to evaluate and test for central auditory processing disorder (CAPD). The requested services, in this case, represent a comprehensive hearing and language evaluation, specifically aimed at ruling out CAPD. The ability to hear and perceive sounds, broadly speaking, is the responsibility of the peripheral hearing organs and central auditory processing center. The peripheral hearing organs include the auricle, ear canal, tympanic membrane (TM) middle ear space, and the cochlea. The organs essentially encode physical acoustic sound waves into neural signals and the signals are then transmitted, via the cochlear nerve, to the central auditory processing center in the brain.
Medical Necessity · 2024 · IMR MN24-40791
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for audiology services to evaluate for central auditory processing disorder (including: Evoked otoacoustic emissions, limited; Comprehensive audiometry threshold evaluation and speech recognition; Tympanometry and Acoustic Reflex Testing; Evaluation of central auditory function, with report initial 60 minutes; and Evaluation of central auditory function, additional 15 minutes). The records provided for review include a history of seizure disorder with multifocal brain lesions, positive anti-nuclear antibody (ANA), and polyarthralgia, with concern for central auditory processing disorder (CAPD) and primary angiitis of the central nervous system (PACNS).
Medical Necessity · 2022 · IMR MN22-36739

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Findings: The physician reviewer found that the patient’s parent has requested authorization and coverage for auditory processing disorder testing to include: (1) evaluation of central auditory function, with report initial 60 minutes, (2) evaluation of central auditory function, additional 15 minutes, (3) comprehensive audiometry threshold evaluation and speech recognition, (4) evoked otoacoustic emissions, limited, and (5) tympanometry and acoustic reflex testing. Testing patients with diagnoses that affect cognition, such as attention deficit hyperactivity disorder (ADHD), can affect the results of a central auditory processing disorder (CAPD) evaluation or render it invalid. Without complete treatment for ADHD, including physician-recommended medication therapy, it is likely that the untreated symptoms of ADHD for this patient would impact the reliability of a CAPD evaluation.
Medical Necessity · 2025 · IMR MN25-46032
The patient is a nine-year-old male who had difficulty learning to read during first grade. He was diagnosed as having a central auditory processing delay by a speech therapist. The patient has received speech therapy since March 2002. The patient’s speech therapist documented delays in auditory memory, interpretation and processing. A request has been made for authorization and coverage for speech therapy. The Health Plan indicates that speech therapy is not medically necessary for treatment of the patient’s clinical condition.Though central auditory processing disorder has been described in the medical literature, the neuropsychologic nature of the disorder is still ill defined and the true nature of the disorder remains unclear. As a result, appropriate treatment has not been well established and no techniques have been validated.
Medical Necessity · 2004 · IMR MN04-3564

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving central auditory processing disorder, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for central auditory processing disorder? Use the California record to prepare.

Explain my denial — freeStart my appeal · $9